Anthony Pare
Keine laufenden Positionen mehr
Vermögen: - $ am 30.04.2024
Profil
Anthony Pare served as the Chief Executive Officer at Bioporto A from 2021 to 2024.
Prior to that, he was the Chief Commercial Officer at Hemanext, Inc. and T2 Biosystems, Inc. He also held the position of VP & General Manager-Global Services at Haemonetics Corp.
In terms of education, he received a graduate degree from George Washington University and an undergraduate degree from Maine Maritime Academy.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
BIOPORTO A/S
-.--% | 31.12.2022 | 0 ( -.--% ) | - $ | 30.04.2024 |
Ehemalige bekannte Positionen von Anthony Pare
| Unternehmen | Position | Ende |
|---|---|---|
| BIOPORTO A/S | Vorstandsvorsitzender | 09.01.2024 |
| T2 BIOSYSTEMS, INC. | Corporate Officer/Principal | 08.11.2021 |
Hemanext, Inc.
 Hemanext, Inc. Medical SpecialtiesHealth Technology Hemanext, Inc. develops blood storage systems. Its technology includes anaerobic storage, background on stored blood, science of storage lesion, and clinical implications. The company was founded by Martin A. Cannon and is headquartered in Lexington, MA. | Corporate Officer/Principal | - |
| HAEMONETICS CORPORATION | Corporate Officer/Principal | - |
Ausbildung von Anthony Pare
| Maine Maritime Academy | Undergraduate Degree |
| George Washington University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| HAEMONETICS CORPORATION | Health Technology |
| T2 BIOSYSTEMS, INC. | Health Technology |
| BIOPORTO A/S | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Hemanext, Inc.
Hemanext, Inc. Medical SpecialtiesHealth Technology Hemanext, Inc. develops blood storage systems. Its technology includes anaerobic storage, background on stored blood, science of storage lesion, and clinical implications. The company was founded by Martin A. Cannon and is headquartered in Lexington, MA. | Health Technology |
